BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
302.49
-8.30 (-2.67%)
At close: Apr 6, 2026, 4:00 PM EDT
302.49
0.00 (0.00%)
Pre-market: Apr 7, 2026, 4:01 AM EDT

BeOne Medicines AG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
33,54233,67819,71218,86222,94427,818
Market Cap Growth
18.08%70.85%4.51%-17.79%-17.52%17.53%
Enterprise Value
30,08731,05318,14716,58418,98121,873
Last Close Price
302.49303.81184.71180.36219.94270.93
PE Ratio
122.47123.00-30.23-21.34-11.35-17.22
Forward PE
55.0166.95----
PS Ratio
6.286.305.177.6716.2023.65
PB Ratio
7.697.725.925.335.234.54
P/TBV Ratio
7.877.905.845.325.184.10
P/FCF Ratio
35.6235.76-31.13-10.97-12.59-17.81
P/OCF Ratio
29.7529.87-140.17-16.30-15.33-21.42
EV/Sales Ratio
5.635.814.766.7413.4118.60
EV/EBITDA Ratio
51.9852.74-45.78-14.81-11.01-15.71
EV/EBIT Ratio
67.2969.45-31.94-13.73-10.61-15.20
EV/FCF Ratio
31.9532.97-28.66-9.65-10.42-14.01
Debt / Equity Ratio
0.440.440.320.260.130.11
Debt / EBITDA Ratio
3.403.40-2.72-0.83-0.35-0.50
Debt / FCF Ratio
2.122.12-1.70-0.54-0.33-0.44
Net Debt / Equity Ratio
-0.58-0.58-0.46-0.64-0.90-0.97
Net Debt / EBITDA Ratio
-4.33-4.333.902.012.294.25
Net Debt / FCF Ratio
-2.70-2.702.441.312.163.79
Asset Turnover
0.760.760.650.400.190.17
Inventory Turnover
1.211.211.301.091.090.99
Quick Ratio
2.962.961.491.963.214.44
Current Ratio
3.413.411.802.323.554.76
Return on Equity (ROE)
7.46%7.46%-18.77%-22.26%-38.11%-29.15%
Return on Assets (ROA)
4.36%4.36%-11.72%-21.17%-24.52%-20.63%
Return on Invested Capital (ROIC)
14.88%14.88%-37.20%-95.77%-167.83%-198.53%
Return on Capital Employed (ROCE)
8.88%8.88%-14.76%-27.12%-30.21%-25.11%
Earnings Yield
0.86%0.81%-3.31%-4.69%-8.81%-5.81%
FCF Yield
2.81%2.80%-3.21%-9.12%-7.94%-5.61%
Buyback Yield / Dilution
-7.75%-7.75%-0.86%-1.22%-11.15%-11.16%
Total Shareholder Return
-7.75%-7.75%-0.86%-1.22%-11.15%-11.16%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q